Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

239 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Non-Helicobacter pylori and non-NSAID peptic ulcer disease in the Japanese population
Nishikawa K, et al. Eur J Gastroenterol Hepatol 2000. Among authors: Kagaya H. PMID 10912481
The status of H. pylori infection in the background population may influence the incidence of H. pylori-negative peptic ulcer disease. ...RESULTS: Of the 246 patients with GU, 12 patients (4.9%) were considered to be H. pylori-negative. Of the 152 patients with DU, two patients (1.3%) were considered to be H. pylori-negative. ...
The status of H. pylori infection in the background population may influence the incidence of H. pylori-negative peptic ulcer …
Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy
Nishikawa K, et al. J Gastroenterol 1999 - Clinical Trial. Among authors: Kagaya H. PMID 10616770
H. pylori status was determined by the rapid urease test, culture, histology, and 13C-urea breath test before and at least 4 weeks after the end of therapy. ...
H. pylori status was determined by the rapid urease test, culture, histology, and 13C-urea breath test before and at least 4 weeks af
Ten minute 13C-urea breath test for the diagnosis of Helicobacter pylori infection
Kato M, et al. J Gastroenterol 1998 - Clinical Trial. Among authors: Kagaya H. PMID 9840016
There were no significant differences between the diagnosis of H. pylori infection at 1 month and more than 3 months after the endpoint of eradication treatment. The 10-min 13C-UBT is suitable for the diagnosis of H. pylori infection before and after eradication treatment....
There were no significant differences between the diagnosis of H. pylori infection at 1 month and more than 3 months after the endpoi …
Role of Helicobacter pylori in chronic gastritis: a prospective study
Kudo M, et al. J Clin Gastroenterol 1995. Among authors: Kagaya H. PMID 8775014
The frequency of MN and PMN cell infiltration in H. pylori-positive patients was significantly higher than that in H. pylori-negative patients. ...There was no significant difference between serum pepsinogen I (PG I) levels in H. pylori-positive and -negative patients. However serum PG II levels were significantly increased in H. pylori-positive patients aged 40-69 years. ...
The frequency of MN and PMN cell infiltration in H. pylori-positive patients was significantly higher than that in H. pylori-n …
Clinical efficacy of lansoprazole in eradication of Helicobacter pylori
Katoh M, et al. J Clin Gastroenterol 1995 - Clinical Trial. Among authors: Kagaya H. PMID 7594324
The eradication rates of H. pylori for gastric ulcer patients were 21 and 54% in groups 1 and 2, respectively (p < 0.05). The H. pylori eradication rates for duodenal ulcer patients were 5 and 73% in groups 1 and 2, respectively (p < 0.001). The H. pylori eradication rates in group 2 were significantly higher than in group 1. Lansoprazole was effective for eradicating H. pylori in this study....

The eradication rates of H. pylori for gastric ulcer patients were 21 and 54% in groups 1 and 2, respectively (p < 0.05). The H

A prospective evaluation of new rapid urease tests before and after eradication treatment of Helicobacter pylori, in comparison with histology, culture and 13C-urea breath test
Nishikawa K, et al. Gastrointest Endosc 2000. Among authors: Kagaya H. PMID 10650258
METHODS: A total of 278 patients, including 115 patients who had not undergone eradication of H pylori and 163 patients after eradication treatment, were enrolled. ...For the Helicocheck, determination of the infection status of H pylori by biopsies from the gastric body had a significantly higher sensitivity than antral biopsies. ...
METHODS: A total of 278 patients, including 115 patients who had not undergone eradication of H pylori and 163 patients after eradica …
Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection and CYP2C19 genetic polymorphism
Hokari K, et al. Aliment Pharmacol Ther 2001 - Clinical Trial. Among authors: Kagaya H. PMID 11552922
CONCLUSIONS: Triple therapy with 10 mg of rabeprazole combined with amoxicillin/clarithromycin is effective for Japanese patients with H. pylori infection, and the H. pylori eradication rate is not affected by CYP2C19 genetic polymorphism....
CONCLUSIONS: Triple therapy with 10 mg of rabeprazole combined with amoxicillin/clarithromycin is effective for Japanese patients with H
[Recent guidelines for the management of Helicobacter pylori infection]
Kato M, et al. Nihon Rinsho 2001 - Review. Among authors: Kagaya H. PMID 11218393 Japanese.
The guidelines for the diagnosis and treatment of H. pylori infection have been developed in Europe, United States, Asia, and Japan. ...In this article, European and Japanese recent statement for the management of H. pylori infection were introduced to reveal the differences in indication, diagnosis, and treatment between both guidelines....
The guidelines for the diagnosis and treatment of H. pylori infection have been developed in Europe, United States, Asia, and Japan. …
239 results
Jump to page
Feedback